Skip to main content

Alexandra Stefanovic

Associate Professor of Medicine
Medicine, Hematologic Malignancies and Cellular Therapy
Box 3961 Med Ctr, Durham, NC 27710
Hematologic Malignancies, Suite 5000, Durham, NC 27705

Overview


I am convinced that caring for patients with malignant hematologic diseases requires not only up-to-date medical knowledge, but also an understanding of the individual patient's needs and circumstances. I encourage patients to take an active role in their treatment and recovery and I work with them to develop an individualized treatment plan that includes the most advanced therapies available today. My practice focuses primarily on disorders of the lymphatic system (Hodgkin and non-Hodgkin lymphoma and chronic lymphocytic leukemia). As an integral part of my clinical activities, I am dedicated to teaching young physicians at all levels of training and educating the next generation of hematologists.

Current Appointments & Affiliations


Associate Professor of Medicine · 2021 - Present Medicine, Hematologic Malignancies and Cellular Therapy, Medicine

Recent Publications


Disparities in CAR-T Therapy Access and Outcomes: Variation in Referral Patterns for CAR-T Therapy in Patients with Newly Diagnosed Malignancies at an Academic Center in North Carolina

Conference Blood · November 5, 2024 Introduction: Chimeric Antigen Receptor (CAR)- T cell therapy has revolutionized the treatment of hematologic malignancies. However, access to CAR-T therapy remains limited, especially fo ... Full text Cite

Cutaneous Vasculopathy and Recalcitrant Lower-Extremity Ulcerations

Journal Article Annals of Internal Medicine Clinical Cases · April 1, 2023 Lower-extremity ulcerations are a frequent cause of hospitalization, and those that persist despite appropriate treatment warrant careful scrutiny. We present a case of chronic, progressive leg ulcerations in a young woman accompanied by oral and genital u ... Full text Cite

An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma.

Journal Article Blood Adv · April 12, 2022 Extranodal marginal zone lymphoma (EMZL) is a heterogeneous non-Hodgkin lymphoma. No consensus exists regarding the standard-of-care in patients with advanced-stage disease. Current recommendations are largely adapted from follicular lymphoma, for which be ... Full text Link to item Cite
View All Publications

Education, Training & Certifications


University of Cologne, Faculty of Medicine (Germany) · 1999 M.D.